Swiss Parenterals Profile
Key Indicators
- Authorised Capital ₹ 12.00 Cr
as on 24-10-2024
- Paid Up Capital ₹ 5.58 Cr
as on 24-10-2024
- Company Age 27 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 82.90 Cr
as on 24-10-2024
- Revenue -11.03%
(FY 2023)
- Profit -27.31%
(FY 2023)
- Ebitda -29.44%
(FY 2023)
- Net Worth 26.49%
(FY 2023)
- Total Assets 22.54%
(FY 2023)
About Swiss Parenterals
The Corporate was formerly known as Swiss Hospital Pvt Ltd. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 12.00 Cr and a paid-up capital of Rs 5.58 Cr.
The company has closed loans amounting to ₹82.90 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Swiss Parenterals Limited India is Piyush Thakkar as CFO. Kaushal Shah, Naishadh Shah, Sachin Shah, and One other member serve as directors at the Company.
- CIN/LLPIN
U85110GJ1997PLC031645
- Company No.
031645
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
04 Feb 1997
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Swiss Parenterals Limited offer?
Swiss Parenterals Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Malaria Medicine.
Who are the key members and board of directors at Swiss Parenterals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Piyush Thakkar  | CFO | 31-Dec-2016 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Naishadh Shah | Whole-Time Director | 01-May-2007 | Current |
| Kaushal Shah | Additional Director | 18-Apr-2024 | Current |
| Sachin Shah | Additional Director | 18-Apr-2024 | Current |
| Krishnakumar Vaidyanathan | Additional Director | 18-Apr-2024 | Current |
Financial Performance and Corporate Structure Insights of Swiss Parenterals.
Swiss Parenterals Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 11.03% decrease. The company also saw a substantial fall in profitability, with a 27.31% decrease in profit. The company's net worth Soared by an impressive increase of 26.49%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Swiss Parenterals?
In 2023, Swiss Parenterals had a promoter holding of 99.99% and a public holding of 0.01%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Eris M. J. Biopharm Private LimitedActive 22 years 3 monthsKaushal Shah and Krishnakumar Vaidyanathan are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of India Creation Date: 30 Dec 2006 | ₹5.78 M | Satisfied |
Bank Of India Creation Date: 27 Sep 2006 | ₹39.75 Cr | Satisfied |
Bank Of India Creation Date: 22 Aug 2006 | ₹39.75 Cr | Satisfied |
How Many Employees Work at Swiss Parenterals?
Swiss Parenterals has a workforce of 283 employees as of Aug 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Swiss Parenterals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Swiss Parenterals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
